MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
sale of equity
$14,454,941
Proceeds from employee
stock purchases and...
$440,309
Net cash provided by
financing activities
$14,721,897
Canceled cashflow
$173,353
Net increase in cash
and cash...
$8,783,300
Canceled cashflow
$5,938,597
Purchase of treasury
shares to satisfy tax...
$173,353
Share-based compensation
$2,673,997
Other operating
assets and liabilities
-$1,908,600
Accrued liabilities and
other current...
$720,196
Accounts payable
$689,710
Depreciation
$181,745
Loss on disposal of
assets
-$169,800
Change in fair value of
related party note
$154,832
Interest accrued on
related party note
$100,000
Net cash used in
operating activities
-$5,925,168
Effect of exchange rate
changes on cash
-$13,429
Canceled cashflow
$6,598,880
Net loss
-$12,494,260
Prepaid expenses
$29,788
Back
Back
Cash Flow
source: myfinsight.com
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)